DAGola™
Search documents
UMeWorld Limited Outlines Strategy 2026: Scaling Global Biofuel Infrastructure and Functional Nutrition Platforms
Globenewswire· 2026-01-06 13:00
Core Insights - UMeWorld Limited is transitioning to industrial-scale commercialization of its enzymatic biorefining solutions for renewable fuels and functional nutrition through its Strategy 2026 initiative [1][2] Group 1: Biofuel Strategy - The company is focusing on scaling its biofuel platform in Malaysia to capture the Sustainable Aviation Fuel (SAF) market opportunity [2] - A planned enzymatic biofuel facility in Malaysia will have an annual capacity of 10,000 tonnes, utilizing local waste-based feedstock such as used cooking oil and palm oil mill effluent (POME) [3][9] - The facility is designed to meet the EU's ReFuelEU Aviation carbon-intensity requirements, positioning it for eligibility under EU sustainability frameworks [3][9] - UMeWorld's biofuel strategy aims to address the feedstock constraints that limit global SAF adoption [7] Group 2: Revenue and Market Expansion - The company is experiencing strong commercial momentum in the Asia-Pacific region, with projected January 2026 revenue exceeding USD $1.10 million, marking an eight-fold increase from initial revenue [4][17] - UMeWorld is pursuing market-entry initiatives in South Korea and Japan to support long-term growth in the region [4] Group 3: Functional Nutrition - UMeWorld is expanding its enzymatic processing capabilities into a high-margin B2B ingredient strategy, supplying clinically validated diacylglycerol (DAG) oils to global food manufacturers [5] - The DAGola™ brand serves as a proof-of-concept for the company's enzymatic processing platform, demonstrating its ability to execute localized production and distribution strategies [11] Group 4: Corporate Governance and Capital Markets - The company is preparing for a potential uplisting to the NYSE American or Nasdaq, aiming to attract institutional capital focused on ESG and energy transition [6][15] - UMeWorld completed a statutory merger in October 2025, establishing a Delaware corporation as the surviving legal entity to support its U.S. reporting framework [12] Group 5: Operational Strategy - UMeWorld has engaged an international biofuel engineering group to assist with the detailed design and project management of the Malaysia facility, aiming to validate its enzymatic process at an industrial scale [8][10] - The company is also identifying a qualified general contractor for the construction of the pilot facility, focusing on site selection based on feedstock availability and logistics [9]
UMeWorld Positions DAGola™ for Strong Q4 Revenue Surge with U.S. E-Commerce and China Market Expansion
Globenewswire· 2025-07-22 12:00
Core Insights - UMeWorld Limited is expanding its flagship product, DAGola™, a clinically validated cooking oil that utilizes advanced enzymatic technology to produce high-purity diacylglycerol (DAG) [1][9] Product Overview - DAGola™ is formulated to meet the increasing global demand for healthier cooking oils, supporting fat metabolism and clinically proven to reduce triglycerides and lower uric acid levels, which are critical markers for metabolic syndrome, obesity, and gout [2][6] Market Expansion - DAGola™ is now available on Walmart Marketplace and Amazon, providing access to approximately 80% of online grocery shoppers in the U.S., which is expected to significantly boost U.S. revenue in Q4 2025 [3][7] - In China, UMeWorld is collaborating with leading national distributors to launch DAGola™ across online and offline channels, targeting the $25 billion edible oil market [5][8] Marketing Strategy - The company is initiating a targeted micro-influencer marketing program to enhance brand awareness and drive product trials, with plans to secure shelf space in mass-market retail chains [4][7] Scientific Validation - Clinical studies indicate that DAGola™ can reduce postprandial triglyceride formation by up to 80%, improve lipid metabolism, and support cardiovascular and metabolic health, positioning it favorably in the global edible oil market [6][9] Future Outlook - UMeWorld is well-positioned to execute its 2025 commercial roadmap, with expectations of significant contributions to top-line growth and global brand equity [7] - The company is also pursuing international expansion opportunities in Europe and Japan, aiming to leverage strategic partnerships and localized marketing initiatives [8]